| Field | Specification |
|---|---|
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of ADMA concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Universal ADMA. During the reaction, Universal ADMA in the sample or standard competes with a fixed amount of Universal ADMA on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Universal ADMA. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Universal ADMA in tested samples can be calculated by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 9.38 ng/mL |
|---|---|
| Detection Range | 15.63-1000 ng/mL |
| Total Assay Time | 2 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Universal (multi-species validated) |
| Detection Method | Competitive |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Universal ADMA in samples.No significant cross-reactivity or interference between Universal ADMA and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 9.38 ng/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 2 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Competitive ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant ADMA standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Early manifestation of aging-related vascular dysfunction in human penile vasculature—A potential explanation for the role of erectile dysfunction as a harbinger of systemic vascular disease (2021) GeroScience. 10.1007/s11357-021-00507-x
Urolithiasis Develops Endothelial Dysfunction as a Clinical Feature (2021) Antioxidants. 10.3390/antiox10050722
Chronic stress promotes pancreatic ductal adenocarcinoma progression via complement C5a-recruited myeloid-derived suppressor cells (2025) CANCER IMMUNOLOGY IMMUNOTHERAPY. 10.1007/s00262-025-04249-z
Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats. (2022) Frontiers in Medicine. 10.3389/fmed.2022.953749
Esomeprazole Decreases Soluble Fms-like Tyrosine Kinase-1 in Preeclamptic Pregnancy in Rats (2026) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms27073105
Endothelial Impairment in HIV-Associated Preeclampsia: Roles of Asymmetric Dimethylarginine and Prostacyclin (2025) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms26157451
HMGA1 promotes the progression of lung adenocarcinoma through the STAT1-mediated transcriptional activation of DDAH1 (2025) Biology Direct. 10.1186/s13062-025-00688-x
Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice (2020) JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 10.1111/jcmm.15278
Cardiovascular Risk Factors and Their Relationship with Vascular Dysfunction in South African Children of African Ancestry (2021) Journal of Clinical Medicine. 10.3390/jcm10020354
Association between protein arginine N-methyltransferase 1 polymorphism and overt diabetic nephropathy: Role of asymmetric dimethylarginine in vascular tone (2024) Journal of Clinical and Translational Endocrinology. 10.1016/j.jcte.2024.100351
Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy (2017) NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 10.1016/j.niox.2017.10.006
Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma (2020) Metabolites. 10.3390/metabo11010010
Levothyroxine therapy reduces endocan and total cholesterol concentrations in patients with subclinical hypothyroidism (2024) Biochemia Medica. 10.11613/BM.2025.010703
DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls (2019) NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 10.1016/j.niox.2019.08.001
Associations of inflammatory markers and vascular cell adhesion molecule-1 with endothelial dysfunction in collagen-induced arthritis (2019) EUROPEAN JOURNAL OF PHARMACOLOGY. 10.1016/j.ejphar.2019.172786
Asymmetric dimethylarginine mediates oxidative stress and atrial remodeling in HL-1 cells (2025) Frontiers in Medicine. 10.3389/fmed.2025.1696845
Fermented soybean enhances post-meal response in appetite-regulating hormones among Indonesian girls with obesity (2021) Obesity Research & Clinical Practice. 10.1016/j.orcp.2021.06.005
Blood pressure response to exercise in unaffected relatives of autosomal dominant polycystic kidney disease patients: an observational study (2023) INTERNATIONAL UROLOGY AND NEPHROLOGY. 10.1007/s11255-023-03535-y
Unveiling NOSTRIN as a potential diagnostic marker of vascular impairment in MASLD (2025) SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 10.1080/00365521.2025.2563587
Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension (2023) Egyptian Heart Journal. 10.1186/s43044-023-00395-w
Comparison between the Effects of Bretschneider’s HTK Solution and Cold Blood Cardioplegia on Systemic Endothelial Functions in Patients who Undergo Coronary Artery Bypass Surgery: a Prospective Randomized and Controlled Trial (2020) Brazilian Journal of Cardiovascular Surgery. 10.21470/1678-9741-2019-0327
Gut permeability is associated with hypertension and measures of obesity but not with Endothelial Dysfunction in South African youth (2021) African Health Sciences. 10.4314/ahs.v21i3.26
Comparison of asymmetric dimethylarginine levels between pre- and post-menopausal women - a cross-sectional study from Rawalpindi. (2019) JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION. 10.5455/jpma.296507
Asymmetric Dimethylarginine in COPD Exacerbation (2022) Medical Bulletin of Sisli Etfal Hospital. 10.14744/SEMB.2022.23682
New markers of oxidative stress in lichen planus and the influence of hepatitis C virus infection - a pilot study (2021) Romanian Journal of Internal Medicine. 10.2478/rjim-2021-0017
